Fanapt
Product Images NDC 69189-0597

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fanapt (NDC 69189-0597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Iloperidone 4 mg Tablet (6918905971)

Packaging label for FANAPT 4 mg tablet containing iloperidone. The label shows manufacturing by Novartis, includes a hospital lot number and expiration date of 02/08/2017. NDC number 69189-0597 is printed, and the labeler listed is Avera McKennan, Sioux Falls, SD.*

FDA Label Image

Tablet Imprint (Fanapt 01)

The image shows a FANAPT drug packaging label with the proprietary name FANAPT prominently displayed. The label mentions Avera McKennan Hospital as the labeler and includes the product NDC 69189-0597. The label also has standard medication information sections such as indications, administration instructions, and warnings.*

FDA Label Image

Fanapt Structural Formula (Fanapt 02)

Chemical structure diagram of the active ingredient in FANAPT, showing the molecular arrangement and bonds between atoms including fluorine, nitrogen, oxygen, and carbon groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.